Similar articles

• Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.

  Petersen SL. Petersen SL. Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
• Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?

  Ringdén O, Schaffer M, Le Blanc K, Persson U, Hauzenberger D, Abedi MR, Olerup O, Ljungman P, Remberger M. Ringdén O, et al. Biol Blood Marrow Transplant. 2004 Feb;10(2):128-34. doi: 10.1016/j.bbmt.2003.10.001. Biol Blood Marrow Transplant. 2004. PMID: 14750078
• Cytokine gene expression in peripheral blood mononuclear cells and alloreactivity in hematopoietic cell transplantation with nonmyeloablative conditioning.

  Petersen SL, Madsen HO, Ryder LP, Svejgaard A, Dickmeiss E, Vindeløv LL. Petersen SL, et al. Biol Blood Marrow Transplant. 2006 Jan;12(1):48-60. doi: 10.1016/j.bbmt.2005.09.002. Biol Blood Marrow Transplant. 2006. PMID: 16399568
• The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation.

  Min CK, Lee WY, Min DJ, Lee DG, Kim YJ, Park YH, Kim HJ, Lee S, Kim DW, Lee JW, Min WS, Kim CC. Min CK, et al. Bone Marrow Transplant. 2001 Nov;28(10):935-40. doi: 10.1038/sj.bmt.1703258. Bone Marrow Transplant. 2001. PMID: 11753547
• [Hematopoietic stem cell transplantation].

  Morishima Y. Morishima Y. Nihon Rinsho. 2005 Apr;63 Suppl 4:690-4. Nihon Rinsho. 2005. PMID: 15861730 Review. Japanese. No abstract available.